Multigene panel testing for hereditary breast/ovarian cancer risk assessment
Friday, August 14, 2015 - 10:30
in Health & Medicine
Multigene testing of women negative for BRCA1 and BRCA2 found some of them harbored other harmful genetic mutations, most commonly moderate-risk breast and ovarian cancer genes and Lynch syndrome genes, which increase ovarian cancer risk, according to an article.